These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12969982)

  • 1. Platelet ADP receptors contribute to the initiation of intravascular coagulation.
    Leon C; Alex M; Klocke A; Morgenstern E; Moosbauer C; Eckly A; Spannagl M; Gachet C; Engelmann B
    Blood; 2004 Jan; 103(2):594-600. PubMed ID: 12969982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of ADP receptors in platelet function.
    Murugappa S; Kunapuli SP
    Front Biosci; 2006 May; 11():1977-86. PubMed ID: 16368572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk.
    van der Meijden PE; Feijge MA; Giesen PL; Huijberts M; van Raak LP; Heemskerk JW
    Thromb Haemost; 2005 Jun; 93(6):1128-36. PubMed ID: 15968399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.
    Foster CJ; Prosser DM; Agans JM; Zhai Y; Smith MD; Lachowicz JE; Zhang FL; Gustafson E; Monsma FJ; Wiekowski MT; Abbondanzo SJ; Cook DN; Bayne ML; Lira SA; Chintala MS
    J Clin Invest; 2001 Jun; 107(12):1591-8. PubMed ID: 11413167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akt activation in platelets depends on Gi signaling pathways.
    Kim S; Jin J; Kunapuli SP
    J Biol Chem; 2004 Feb; 279(6):4186-95. PubMed ID: 14623889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs.
    Gachet C
    Pharmacol Ther; 2005 Nov; 108(2):180-92. PubMed ID: 15955565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities.
    Frelinger AL; Jakubowski JA; Li Y; Barnard MR; Linden MD; Tarnow I; Fox ML; Sugidachi A; Winters KJ; Furman MI; Michelson AD
    J Thromb Haemost; 2008 Feb; 6(2):359-65. PubMed ID: 18021304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity.
    Leon C; Ravanat C; Freund M; Cazenave JP; Gachet C
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1941-7. PubMed ID: 12933533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A complementary role for tetraspanin superfamily member CD151 and ADP purinergic P2Y12 receptor in platelets.
    Makkawi M; Moheimani F; Alserihi R; Howells D; Wright M; Ashman L; Jackson DE
    Thromb Haemost; 2015 Nov; 114(5):1004-19. PubMed ID: 26245294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
    Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
    Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel.
    Hechler B; Eckly A; Ohlmann P; Cazenave JP; Gachet C
    Br J Haematol; 1998 Dec; 103(3):858-66. PubMed ID: 9858246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of clopidogrel administration to healthy volunteers on platelet phosphorylation events triggered by ADP.
    Contreres JO; Dupuy E; Job B; Habib A; Bryckaert M; Rosa JP; Simoneau G; Herbert JM; Savi P; Levy-Toledano S
    Br J Haematol; 2003 Feb; 120(4):633-42. PubMed ID: 12588350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist.
    Léon C; Freund M; Ravanat C; Baurand A; Cazenave JP; Gachet C
    Circulation; 2001 Feb; 103(5):718-23. PubMed ID: 11156884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The P2Y1 receptor plays an essential role in the platelet shape change induced by collagen when TxA2 formation is prevented.
    Mangin P; Ohlmann P; Eckly A; Cazenave JP; Lanza F; Gachet C
    J Thromb Haemost; 2004 Jun; 2(6):969-77. PubMed ID: 15140133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of inhibition of P2Y(1) and P2Y(12) on whole blood clotting, coagulum elasticity and fibrinolysis resistance studied with free oscillation rheometry.
    Ramström S; Rånby M; Lindahl TL
    Thromb Res; 2003 Mar; 109(5-6):315-22. PubMed ID: 12818256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of localized thrombosis in P2Y1-deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist.
    Lenain N; Freund M; Léon C; Cazenave JP; Gachet C
    J Thromb Haemost; 2003 Jun; 1(6):1144-9. PubMed ID: 12871312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of P2Y(1) receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrel.
    Labarthe B; Babin J; Bryckaert M; Théroux P; Bonnefoy A
    Br J Pharmacol; 2012 May; 166(1):221-31. PubMed ID: 21950486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity.
    Niitsu Y; Jakubowski JA; Sugidachi A; Asai F
    Semin Thromb Hemost; 2005 Apr; 31(2):184-94. PubMed ID: 15852222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression.
    Reiner MF; Akhmedov A; Stivala S; Keller S; Gaul DS; Bonetti NR; Savarese G; Glanzmann M; Zhu C; Ruf W; Yang Z; Matter CM; Lüscher TF; Camici GG; Beer JH
    Cardiovasc Res; 2017 Jan; 113(1):61-69. PubMed ID: 28028070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.
    Savi P; Herbert JM
    Semin Thromb Hemost; 2005 Apr; 31(2):174-83. PubMed ID: 15852221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.